U.S. & Israeli Innovations in the Life Sciences: Part 2
Jewish National Fund
Israel Practice co-chair Meital Stavinsky will moderate a webinar hosted by the Jewish National Fund titled "U.S. & Israeli Innovations in the Life Sciences: Part 2." The panel will include industry professionals from the BioTech and Pharmaceutical sectors of Israel and Miami. Participants will learn about the potential COVID-19 "cure" Allocetra developed by Enlivex Therapeutics from Chief Scientific & Medical Officer Dror Mevorach. The program will also include a discussion with a Miami & Israeli BioTech Panel featuring Isaac Litman, Founder & CEO of Neteera Technologies, Dr. Osnat Sela Tavor, CTO of Nanose Medical, and Andrew Satz, CEO of EVQLV.